New Delhi, May 20 -- Genetic specialists from across the globe gathered in the halls of the Los Angeles Convention Center last month for the 2025 American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting.

From March 18-22, 2025, the convention center transformed into a hub of genetic innovation. Attendees discussed breakthroughs in new testing methods and diagnostic approaches. BioLogic Pharma Solutions participated in the meeting. The company highlighted a critical blind spot in genetic testing protocols through its investigation of diagnostic gaps in SHANK3-related disorders, a rare genetic form of autism spectrum disorder (ASD).

The Gathering of Genetic Minds

The ACMG annual meeting has long served as...